Comparison of PPARδ and PPARγ in inhibiting the pro-inflammatory effects of C-reactive protein in endothelial cells

International Journal of Cardiology

Volumn 143, Issue 3, 2010, Pages 361-367

  Liang, Yao Jen ^a   Liu, Yuan Chun ^b   Chen, Chao Yi ^a   Lai, Ling Ping ^c   Shyu, Kou Gi ^d,e   Juang, Shiow Jen ^f   Wang, Bao Wei ^e   Leu, Jyh Gang ^e,g  

^a FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^b UNIVERSITY OF PITTSBURGH   (United States)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^e SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^f TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^g FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Atherosclerosis; CRP; Endothelium dysfunction; Inflammation; PPAR

Indexed keywords

4 [4 [3 (4 ACETYL 3 HYDROXY 2 PROPYLPHENOXY)PROPOXY]PHENOXY]ACETIC ACID; C REACTIVE PROTEIN; CD32 ANTIGEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 8; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR DELTA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TROGLITAZONE; VASCULAR CELL ADHESION MOLECULE 1;

ARTICLE; ATHEROSCLEROSIS; CELL ADHESION; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG EFFECT; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INFLAMMATION; MONOCYTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; UMBILICAL VEIN;

ATHEROSCLEROSIS; C-REACTIVE PROTEIN; CELL COMMUNICATION; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG INTERACTIONS; ENDOTHELIAL CELLS; GENE EXPRESSION; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MONOCYTES; NF-KAPPA B; PPAR DELTA; PPAR GAMMA; RECEPTORS, IGG; UMBILICAL VEINS; VASCULITIS;

EID: 77956616203     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.03.100     Document Type: Article

References (28)

1. P.M. Ridker, M.J. Stampfer, and N. Rifai Novel risk factors for systemic atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein, and standard cholesterol screening as predictors of peripheral arterial disease JAMA 285 2001 2481 2485
2. P.M. Ridker, N. Rifai, L. Rose, J.E. Buring, and N.R. Cook Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events N Engl J Med 347 2002 1557 1565
3. P. Libby, and M. Aikawa Stabilization of atherosclerotic plaques: new mechanisms and clinical targets Nat Med 8 2002 1257 1262
4. P. Libby Inflammation in atherosclerosis Nature 420 2002 868 874
5. P.J. Brown, T.A. Smith-Oliver, and P.S. Charifson Identification of peroxisome proliferators-activated receptor ligands from a biased chemical library Chem Biol 4 1997 909 918
6. H.E. Xu, M.H. Lambert, and V.G. Montana Molecular recognition of fatty acids by peroxisome proliferators-activated receptors Mol Cell 3 1999 397 403
7. M. Ricote, A.F. Valledor, and C.K. Glass Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis Arterioscler Thromb Vasc Biol 24 2004 230 239
8. G. Chinetti, J.C. Fruchart, and B. Staels Peroxisome proliferators- activated receptors and inflammation: from basic science to clinical applications Int J Obes Relat Metab Disord 27 2003 S41 S45
9. L. Michalik, B. Desvergne, C. Dreyer, M. Gavillet, R.N. Laurini, and W. Wahli PPAR expression and function during vertebrate development Int J Dev Biol 46 2002 105 114
10. Y. Barak Effects of peroxisome proliferator-activated receptor δ on placentation, adiposity, and colorectal cancer Proc Natl Acad Sci USA 99 2002 303 308
11. C.H. Lee, A. Chawla, N. Urbiztondo, D. Liao, W.A. Boisvert, and R.M. Evans Transcriptional repression of atherogenic inflammation: modulation by PPARδ Science 302 2003 453 456
12. H. Vosper, L. Patel, and T.L. Graham The peroxisome proliferators- activated receptor delta promotes lipid accumulation in human macrophages J Biol Chem 276 2001 44258 44265
13. W.R. Oliver, J.L. Shenk, and M.R. Snaith A selective peroxisome proliferators-activated receptor δ agonist promotes reverse cholesterol transport Proc Natl Acad Sci USA 98 2001 5306 5311
14. G.D. Barish, A.R. Atkins, and M. Downes PPARdelta regulates multiple proinflammatory pathways to suppress atherosclerosis Proc Natl Acad Sci USA 105 2008 4271 4276
15. D. Bharadwaj, M.P. Stein, M. Volzer, C. Mold, and T.W. Du Clos The major receptor for C-reactive protein on leukocytes is Fcgamma receptor II J Exp Med 190 1999 585 590
16. S. Devaraj, M.R. Dasu, U. Singh, L.V. Rao, and I. Jialal C-reactive protein stimulates superoxide anion release and tissue factor activity in vivo Atherosclerosis 203 2009 67 74
17. S. Devaraj, B. Davis, S.I. Simon, and I. Jialal CRP promotes monocyte-endothelial cell adhesion via Fcγ receptors in human aortic endothelial cells under static and shear flow conditions Am J Physiol Heart Circ Physiol 291 2006 H1170 H1176
18. Y.J. Liang, K.G. Shyu, B.W. Wang, and L.P. Lai C-reactive protein activates the nuclear factor-κB pathway and induces vascular cell adhesion molecule-1 expression through CD32 in human umbilical vein endothelial cells and aortic endothelial cells J Mol Cell Cardiol 40 2006 412 420
19. G.D. Barish, V.A. Narkar, and R.M. Evans PPAR delta: a dagger in the heart of the metabolic syndrome J Clin Invest 116 2006 590 597
20. S. Devaraj, P.R. Kumaresan, and I. Jialal Effect of C-reactive protein on chemokine expression in human aortic endothelial cells J Mol Cell Cardiol 36 2004 405 410
21. M. Ricote, A.F. Valledor, and C.K. Glass Decoding transcriptional programs regulated by PPARs and LXRs in the macrophage: effects on lipid homeostasis, inflammation, and atherosclerosis Arterioscler Thromb Vasc Biol 24 2004 230 239
22. L. Xie, L. Chang, Y. Guan, and X. Wang C-reactive protein augments interleukin-8 secretion in human peripheral blood monocytes J Cardiovasc Pharmacol 46 2005 690 696
23. R. Kleemann, P.P. Gervois, L. Verschuren, B. Staels, H.M. Princen, and T. Kooistra Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NF kappa B-C/EBP-beta complex formation Blood 101 2003 545 551
24. R. De martin, M. Hoeth, R. Hofer-Warbineck, and J.A. Schmid The transcription factor NF-kappa B and the regulation of vascular cell function Arterioscler Thromb Vasc Biol 20 2000 E83 E88
25. V. Pasceri, J.S. Cheng, J.T. Willerson, and E.T. Yeh Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs Circulation 103 2001 2531 2534
26. A. Kawakami, M. Aikawa, N. Nitta, M. Yoshida, P. Libby, and F.M. Sacks Apolipoprotein CIII-induced THP-1 cell adhesion to endothelial cells involves pertussis toxin-sensitive G protein- and protein kinase C alpha-mediated nuclear factor-kappaB activation Arterioscler Thromb Vasc Biol 27 2007 219 225
27. N. Wang, L. Verna, and N.G. Chen Constitutive activation of peroxisome proliferator-activated receptor-γ suppresses pro-inflammatory adhesion molecules in human vascular endothelial cells J Biol Chem 277 2002 34176 34181
28. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150